ADCY2
-
Official Full Name
adenylate cyclase 2 (brain)
-
Overview
This gene encodes a member of the family of adenylate cyclases, which are membrane-associated enzymes that catalyze the formation of the secondary messenger cyclic adenosine monophosphate (cAMP). This enzyme is insensitive to Ca(2+)/calmodulin, and is stimulated by the G protein beta and gamma subunit complex. -
Synonyms
ADCY2; adenylate cyclase 2 (brain); adenylate cyclase type 2; AC2; HBAC2; KIAA1060; 3,5 cyclic AMP synthetase; Adenylate cyclase II; Adenylate cyclase 2 (brain; Adenylate cyclase 2; Adenylate cyclase type II; ATP pyrophosphate lyase 2; FLJ16822; FLJ45092; MGC133314; Type II adenylate cyclase; adenylyl cyclase 2; ATP pyrophosphate-lyase 2; 3,5-cyclic AMP synthetase;
- Recombinant Proteins
- Protein Pre-coupled Magnetic Beads
- Human
- Rat
- Rhesus Macaque
- E.coli
- E.Coli or Yeast
- HEK293
- Mammalian Cell
- Wheat Germ
- GST
- His
- Fc
- Avi
- T7
- Other Resource
- ADCY2 Related Signal Pathway
ADCY2 involved in several pathways and played different roles in them. We selected most pathways ADCY2 participated on our site, such as , which may be useful for your reference. Also, other proteins which involved in the same pathway with ADCY2 were listed below. Creative BioMart supplied nearly all the proteins listed, you can search them on our site.
Pathway Name | Pathway Related Protein |
---|
ADCY2 has several biochemical functions, for example, . Some of the functions are cooperated with other proteins, some of the functions could acted by ADCY2 itself. We selected most functions ADCY2 had, and list some proteins which have the same functions with ADCY2. You can find most of the proteins on our site.
Function | Related Protein |
---|
ADCY2 has direct interactions with proteins and molecules. Those interactions were detected by several methods such as yeast two hybrid, co-IP, pull-down and so on. We selected proteins and molecules interacted with ADCY2 here. Most of them are supplied by our site. Hope this information will be useful for your research of ADCY2.
Research Area
Related articles
- Reviews
- Q&As
Q&As (11)
Ask a questionYes, studies have suggested that ADCY2-mediated signaling may be involved in the pathogenesis of schizophrenia, and drugs that target ADCY2 activity are being developed as potential treatments for the disease. For example, a range of compounds that selectively inhibit ADCY2 activity have been identified and tested in animal models of schizophrenia, with promising results.
ADCY2 protein has been implicated in various diseases, including diabetes, hypertension, schizophrenia, and addiction. As such, it has been suggested that targeting ADCY2 protein activity could be a therapeutic approach for these conditions. For example, drugs that inhibit ADCY2 protein activity could potentially reduce insulin resistance in diabetes patients or help to mitigate the symptoms of schizophrenia.
While genetic variants in the ADCY2 gene are associated with an increased risk of type 2 diabetes, ADCY2 protein itself has not been widely studied as a diagnostic biomarker for the disease. Other biomarkers, such as blood glucose levels and insulin secretion, are currently used to diagnose type 2 diabetes.
The primary function of ADCY2 protein is to catalyze the formation of cAMP, which is a second messenger that mediates diverse cellular signaling pathways. It is involved in regulating the activity of ion channels, protein kinases, and transcription factors, which ultimately affects the function of various organ systems, including the nervous, cardiovascular, and endocrine systems.
Yes, ADCY2 protein has been identified as a potential therapeutic target for the treatment of heart failure. Studies have shown that reduced ADCY2 expression and activity are associated with impaired cardiac function, while increasing ADCY2 activity can improve cardiac function in animal models of heart failure. As such, drugs that target ADCY2 activity are being developed as potential therapies for heart failure.
ADCY2 protein can be studied in vitro using recombinant protein expression systems or in vivo using animal models. Common techniques used to study ADCY2 protein function include enzyme assays to measure cAMP production, electrophysiology to examine ion channel activity, and genetic manipulation to study the effect of altering ADCY2 gene expression.
While ADCY2 protein is not usually considered a direct target for cancer therapy, the cAMP signaling pathway in which ADCY2 participates has been targeted in some cancer treatments. For example, drugs that activate ADCY2 by increasing cAMP levels have been tested as potential therapies for some types of cancer, including colon cancer and melanoma. Additionally, several other components of the cAMP signaling pathway are known to be important in cancer growth and progression, and drugs that target these proteins are being developed as potential cancer treatments.
At present, there are no FDA-approved drugs that specifically target ADCY2 protein. However, several compounds have been identified that can modulate the activity of adenylate cyclases, including ADCY2. For example, forskolin, which stimulates adenylate cyclase activity, is commonly used as a research tool to increase intracellular cAMP levels. In addition, several drugs that target other components of the cAMP signaling pathway, such as phosphodiesterase inhibitors, have been developed and are used clinically.
Yes, mutations in the ADCY2 gene have been associated with several diseases. For example, a single nucleotide polymorphism (SNP) in the ADCY2 gene has been linked to an increased risk of type 2 diabetes. In addition, mutations in ADCY2 have been associated with familial cases of schizophrenia and bipolar disorder.
While mutations in the ADCY2 gene have been associated with an increased risk of primary open-angle glaucoma, ADCY2 protein itself has not been widely studied as a potential diagnostic biomarker for the disease. Other biomarkers, such as intraocular pressure and optic nerve head anatomy, are currently used to diagnose primary open-angle glaucoma.
ADCY2 protein activity is regulated by several mechanisms. For example, it can be stimulated by G protein-coupled receptors (GPCRs) that activate adenylate cyclase via a G protein-dependent pathway. Other factors that can stimulate ADCY2 protein activity include calcium/calmodulin and forskolin. In addition, the activity of ADCY2 protein can be inhibited by protein kinase A (PKA), which phosphorylates ADCY2 and reduces its activity. Genetic mutations and epigenetic modifications, such as DNA methylation, can also affect the expression and activity of ADCY2 protein.
Ask a Question for All ADCY2 Products
Required fields are marked with *
My Review for All ADCY2 Products
Required fields are marked with *